Elli Leppä

481 total citations
15 papers, 377 citations indexed

About

Elli Leppä is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Elli Leppä has authored 15 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 5 papers in Cognitive Neuroscience. Recurrent topics in Elli Leppä's work include Neuroscience and Neuropharmacology Research (11 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Memory and Neural Mechanisms (4 papers). Elli Leppä is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Memory and Neural Mechanisms (4 papers). Elli Leppä collaborates with scholars based in Finland, Germany and United Kingdom. Elli Leppä's co-authors include A. Linden, William Wisden, Esa R. Korpi, Olga Vekovischeva, Peer Wulff, M. Isabel Aller, Werner Sieghart, Per H. Rosenberg, Jerome D. Swinny and Hartmut Lüddens and has published in prestigious journals such as Nature Neuroscience, PLoS ONE and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Elli Leppä

13 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elli Leppä Finland	9	278	175	106	40	35	15	377
M.E. Pum Germany	12	283 1.0×	137 0.8×	115 1.1×	30 0.8×	15 0.4×	17	394
Rebecca E. Horton United States	7	309 1.1×	193 1.1×	52 0.5×	22 0.6×	39 1.1×	9	477
Patricia Seja Finland	7	329 1.2×	239 1.4×	79 0.7×	53 1.3×	20 0.6×	8	478
Y. Yanovsky Germany	8	322 1.2×	91 0.5×	108 1.0×	29 0.7×	24 0.7×	10	411
Prachi Khare United States	5	203 0.7×	138 0.8×	108 1.0×	23 0.6×	35 1.0×	6	342
Sabine Staak Germany	13	304 1.1×	297 1.7×	113 1.1×	60 1.5×	14 0.4×	16	532
Sawako Arai Japan	7	164 0.6×	98 0.6×	65 0.6×	32 0.8×	13 0.4×	9	319
Karine Jeanneau Switzerland	5	307 1.1×	265 1.5×	76 0.7×	30 0.8×	49 1.4×	7	487
Rosaria Ferrari Italy	9	269 1.0×	247 1.4×	75 0.7×	35 0.9×	32 0.9×	14	454
M. G. FORNARETTO Italy	6	411 1.5×	271 1.5×	77 0.7×	19 0.5×	44 1.3×	10	600

Countries citing papers authored by Elli Leppä

Since Specialization

Citations

This map shows the geographic impact of Elli Leppä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elli Leppä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elli Leppä more than expected).

Fields of papers citing papers by Elli Leppä

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elli Leppä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elli Leppä. The network helps show where Elli Leppä may publish in the future.

Co-authorship network of co-authors of Elli Leppä

This figure shows the co-authorship network connecting the top 25 collaborators of Elli Leppä. A scholar is included among the top collaborators of Elli Leppä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elli Leppä. Elli Leppä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Leppä, Elli, et al.. (2021). Anti-doping knowledge and educational needs of Finnish pharmacists. Performance Enhancement & Health. 9(2). 100195–100195. 8 indexed citations

Niskanen, Leo, Jari Haukka, Elli Leppä, et al.. (2018). Type 2 diabetes and treatment intensification in primary care in Finland. Acta Diabetologica. 55(11). 1171–1179. 10 indexed citations

Leppä, Elli, A. Linden, M. Isabel Aller, et al.. (2016). Increased Motor-Impairing Effects of the Neuroactive Steroid Pregnanolone in Mice with Targeted Inactivation of the GABAA Receptor γ2 Subunit in the Cerebellum. Frontiers in Pharmacology. 7. 403–403. 6 indexed citations

Sipilä, Raija, Miika Linna, Tatu A. Miettinen, et al.. (2014). Kansallisen rekisteritutkimuksen lupamenettelyn sujuvuus - esimerkkinä diabeteksen Käypä hoito -suosituksen toteutuminen. 69(46). 3085–3089.

Sipilä, Raija, Miika Linna, T. A. Miettinen, et al.. (2014). Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland. Value in Health. 17(7). A336–A336.

Linden, A., Ulrich Schmitt, Elli Leppä, et al.. (2011). Ro 15-4513 Antagonizes Alcohol-Induced Sedation in Mice Through αβγ2-type GABAA Receptors. Frontiers in Neuroscience. 5. 3–3. 20 indexed citations

Leppä, Elli, A. Linden, Olga Vekovischeva, et al.. (2011). Removal of GABAA Receptor γ2 Subunits from Parvalbumin Neurons Causes Wide-Ranging Behavioral Alterations. PLoS ONE. 6(9). e24159–e24159. 27 indexed citations

Leppä, Elli, A. Linden, Holger Rabe, et al.. (2011). Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation. European Journal of Pharmacology. 666(1-3). 111–121. 6 indexed citations

Linden, A., M. Isabel Aller, Elli Leppä, et al.. (2008). K+ Channel TASK-1 Knockout Mice Show Enhanced Sensitivities to Ataxic and Hypnotic Effects of GABAA Receptor Ligands. Journal of Pharmacology and Experimental Therapeutics. 327(1). 277–286. 24 indexed citations

10.

Wulff, Peer, Thomas E. Goetz, Elli Leppä, et al.. (2007). From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors. Nature Neuroscience. 10(7). 923–929. 83 indexed citations

11.

Korpi, Esa R., A. Linden, Elli Leppä, et al.. (2007). Does ethanol act preferentially via selected brain GABAA receptor subtypes? the current evidence is ambiguous. Alcohol. 41(3). 163–176. 65 indexed citations

12.

Wulff, Peer, Thomas E. Goetz, Elli Leppä, et al.. (2007). From synapse to behavior: rapid modulation of defined neuronal types with engineered GABA_A receptors. e-Neuroforum. 13(4). 134–136. 8 indexed citations

13.

Linden, A., M. Isabel Aller, Elli Leppä, et al.. (2006). The in Vivo Contributions of TASK-1-Containing Channels to the Actions of Inhalation Anesthetics, the α2 Adrenergic Sedative Dexmedetomidine, and Cannabinoid Agonists. Journal of Pharmacology and Experimental Therapeutics. 317(2). 615–626. 68 indexed citations

14.

Cope, David W., Theofanis Karayannis, Peer Wulff, et al.. (2005). Loss of zolpidem efficacy in the hippocampus of mice with the GABA_A receptor γ2 F77I point mutation. European Journal of Neuroscience. 21(11). 3002–3016. 30 indexed citations

15.

Leppä, Elli, Olga Vekovischeva, A. Linden, et al.. (2005). Agonistic effects of the β-carboline DMCM revealed in GABAA receptor γ2 subunit F77I point-mutated mice. Neuropharmacology. 48(4). 469–478. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact